Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,080 across all filing types
Latest filing 2022-04-28 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
普莱柯非经营性资金占用及其他关联资金往来情况汇总表的专项审计报告
Audit Report / Information Classification · 95% confidence The document is a special report on non-operating fund occupation and other related party fund transactions for the year 2021 by 普莱柯生物工程股份有限公司. It includes audited financial data references and a summary table of related party transactions. The document is issued by an accounting firm with an audit report number and date, indicating it is a standalone audit-related report focusing on specific regulatory requirements about fund occupation and related party transactions. It is not a full annual report (10-K), nor an earnings release or management discussion. It is not a simple announcement or certification but a detailed audit-related report on a specific topic. Therefore, it fits best under Audit Report / Information (AR). The document length is 2008 characters, which is short but contains substantive audited financial data and analysis related to regulatory compliance on fund occupation. FY 2021
2022-04-28 Chinese
普莱柯关于续聘会计师事务所及其费用的公告
Audit Report / Information Classification · 90% confidence The document is an announcement regarding the reappointment of an accounting firm (立信会计师事务所) for auditing the company's 2021 financial report and internal control audit for the year 2022. It details the qualifications, independence, and audit fees of the accounting firm, as well as the approval process by the board and independent directors. The document does not contain actual financial statements or audit results but is a formal announcement about the appointment of the auditor and related fees. The document length is 3022 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this document fits best under the category of Audit Report / Information (AR), as it relates to audit information but is not a full annual report or financial statement itself. FY 2021
2022-04-28 Chinese
普莱柯关于向银行申请综合授信额度的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by the company regarding its intention to apply for a comprehensive credit facility from banks, detailing the credit limits, types of credit, and the approval process including board and shareholder meeting requirements. It does not contain financial statements, audit information, or detailed financial results. It is a financing update related to capital structure and funding plans. The document length is short (747 characters), but it is not merely announcing the publication of a report; it is an announcement of a financing activity. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2022-04-28 Chinese
普莱柯2021年监事会工作报告
Management Reports Classification · 95% confidence The document is titled as the "2021 年监事会工作报告" which translates to "2021 Supervisory Board Work Report". It details the supervisory board's activities, including meetings held, oversight of financial reports, internal controls, related party transactions, and compliance with laws and regulations. It does not contain full financial statements or detailed financial performance data itself but rather a report on the supervisory board's work and oversight activities for the year 2021. The document length is 3194 characters, which is relatively short and consistent with a report rather than a full annual report. This type of document is a management or supervisory board report on company governance and oversight, which fits best under the category of Management Reports (MDA). It is not an Annual Report (10-K) or Audit Report (AR) because it does not contain full financial statements or audit opinions as standalone content. It is not a Regulatory Filing (RNS) because it is a substantive report on supervisory activities. Therefore, the best classification is Management Reports (MDA).
2022-04-28 Chinese
普莱柯关于2021年度利润分配预案的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement from a company regarding its 2021 annual profit distribution plan, including details on cash dividends per share, total dividend amount, reasons for the dividend payout ratio being below 30%, and the decision-making process involving the board of directors, independent directors, and supervisory board. It also mentions that the plan is subject to approval at the upcoming shareholders' meeting. The document is not the full annual report or financial statements but a specific announcement about dividend distribution and related corporate governance matters. This fits the definition of a Notice of Dividend Amount (DIV), which covers announcements of dividend amounts, payment dates, and details for shareholders. The document length is under 5,000 characters, and it contains substantive dividend information rather than just a report publication notice or regulatory filing. Therefore, the appropriate classification is DIV with high confidence.
2022-04-28 Chinese
普莱柯审计委员会2021年度履职情况报告
Audit Report / Information Classification · 95% confidence The document is a detailed report from the Board Audit Committee of 普莱柯生物工程股份有限公司 for the year 2021. It discusses the committee's activities, including supervision and evaluation of the external audit firm, review of financial reports for various periods in 2021, internal audit work, and internal control effectiveness. The content focuses on audit committee duties and audit-related oversight rather than presenting the full audited financial statements or the audit report itself. The document length is 2300 characters, which is relatively short but contains substantive content about audit committee activities rather than just an announcement. It is not a full Annual Report (10-K) or standalone Audit Report (AR) but a report on the audit committee's performance and activities. This fits best with the category of Audit Report / Information (AR), which includes audit reports and related information excluding full annual reports. Therefore, the classification is AR with high confidence. FY 2021
2022-04-28 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.